Dachaigh › Lymphoma Cealla-T › New York

Sgrùdaidhean clionaigeach Lymphoma Cealla-T ann an New York

Tha 15 sgrùdaidhean airson Lymphoma Cealla-T a’ lorg phàirtichean aig làraichean ann an New York.

Bailtean ann an New York

Teacsa sgrùdaidh oifigeil (Beurla)

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
agus 5 a bharrachd

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04803201

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medicine, New York

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06561048

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT04752826

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

University of Rochester, Rochester

A’ fastadhÌre 3

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06724237

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
agus 1 a bharrachd

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05010005

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

Rochester Skin Lymphoma Medical Group. PLLC, Rochester

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06854653

CD4CAR for CD4+ Leukemia and Lymphoma

Albert Einstein Health Network, New York

A’ fastadhÌre 1

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Ògmh 2026 · NCT03829540

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Memorial Sloan Kettering, New York

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Ògmh 2026 · NCT05463263

A Registry for People With T-cell Lymphoma

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Weill Cornell Medical Center (Data Collection Only), New York
agus 2 a bharrachd

A’ fastadhSgrùdadh amharc

Gach aois · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT05978141

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Icahn School of Medicine at Mount Sinai, New York

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Gibl 2026 · NCT05996185

CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

Columbia University Irving Medical Center, New York

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Samh 2025 · NCT06420089

Tissue Repository: CTCL Collection Protocol

Columbia University Irving Medical Center, New York

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Samh 2025 · NCT02840747

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Dàmh 2025 · NCT06534060

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Columbia University, New York

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2025 · NCT04234048

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital New York-Presbyterian, New York
Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1

Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Dùbh 2024 · NCT05476770

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.